PR Newswire - Global X Hang Seng High Dividend Yield ETF Hits US...
HONG KONG, Aug. 14, 2024 /PRNewswire/ -- Mirae Asset Global Investments (Hong Kong) Limited, (the "F...
Read morePR Newswire - In recognition of its market-leading capabilities ...
DOHA, Qatar, Aug. 14, 2024 /PRNewswire/ -- QNB Group, the largest financial institution in the Middl...
Read morePR Newswire - AutoFull M6 Gaming Chair: Built for More Than Just...
NEW YORK, Aug. 14, 2024 /PRNewswire/ -- As e-sports continue to surge in popularity, gaming chairs h...
Read morePR Newswire - SwitchBot Introduces Mini Robot Vacuum K10+ Pro fo...
TOKYO, Aug. 14, 2024 /PRNewswire/ -- SwitchBot, a rising brand in smart home retrofitting and automa...
Read morePR Newswire - Deltek Announces Speaker Lineup and Sponsors for D...
This year's annual user conference will feature José Hernández, Jason Dorsey and Deltek CEO Bob Hugh...
Read morePR Newswire - TAILG Vietnam Smart Manufacturing Base Officially ...
MY HAO, Vietnam, Aug. 14, 2024 /PRNewswire/ -- TAILG, a leading electric two-wheeler company, has of...
Read morePR Newswire - EQT sets target fund size for EQT Private Capital ...
STOCKHOLM, Aug. 15, 2024 /PRNewswire/ -- EQT has today set the target size for EQT Private Capital A...
Read morePR Newswire - S-Tron Shanghai 2024, The Epic Comeback of Former ...
SHANGHAI, Aug. 14, 2024 /PRNewswire/ -- On September 20-21, 2024, the S-Tron Shanghai 2024 Technolog...
Read morePR Newswire - REMOVERY TO PROVIDE 150 FREE TATTOO REMOVAL PACKAG...
On August 14, the world's tattoo removal experts will provide 150 treatments to individuals in need ...
Read morePR Newswire - CHIVAS REGAL SCORES BIG WITH MULTI-YEAR GLOBAL ARS...
The iconic blended Scotch whisky will become the club's Official Whisky Partner celebrating their...
Read morePR Newswire - ADGM Continues Rapid Growth, Issues 1,271 New Lice...
ABU DHABI, UAE, Aug. 15, 2024 /PRNewswire/ -- ADGM, the international financial centre (IFC) of the ...
Read morePR Newswire - Ivonescimab (PD-1/VEGF) Received Priority Review f...
The Second Indication of Ivonescimab in NSCLC2L+ EGFRm NSCLC Already Approved in May 2024 HONG KONG,...
Read more